DARWIN DISCOVERY LIMITED
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 11, 2010 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,075 Total Citation Count
- Oct 05, 1995 Earliest Filing
- 77 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0063,105 PHARMACEUTICAL USES AND SYNTHESIS OF NICOTINANILIDE-N-OXIDESAbandonedOct 18, 06Mar 11, 10[A61K, C07D, G01N, A61P]
7141590 Pharmaceutical uses and synthesis of nicotinanilide-N-oxidesExpiredDec 12, 01Nov 28, 06[A61K]
6884618 Identification of the gene causing the mouse scurfy phenotype and its human orthologExpiredApr 02, 02Apr 26, 05[C07H, C12N]
2005/0026,965 Pharmaceutical uses and synthesis of nicotinanilide-N-oxidesAbandonedFeb 17, 04Feb 03, 05[A61K, C07D]
6794145 Identification of the gene causing the mouse scurfy phenotype and its human orthologExpiredOct 24, 00Sep 21, 04[G01N, C07K]
6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activityExpiredJun 25, 01Mar 16, 04[A61K, C07D]
6683171 Identification of the gene causing the mouse scurfy phenotype and its human orthologExpiredOct 25, 00Jan 27, 04[C07H, C12Q, C12P, C12N]
6667162 Identification of the gene causing the mouse scurfy phenotype and its human orthologExpiredOct 25, 00Dec 23, 03[C07H, C12P, C12N, C07K]
6566384 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activityExpiredNov 13, 01May 20, 03[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
